SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bazer who wrote (967)7/6/1998 11:45:00 PM
From: Ed Ajootian   of 10280
 
Bazer,

Thanks again for the very helpful comments.

Will be interesting if the FDA lets them include special dosages for the kids. This would make sense based on SEPR's pediatric study but you never know what the FDA is thinking.

I talked with a pretty high-level biotech executive at one point about FDA actions and this person said that the FDA is tacitly run by the large pharmaceutical companies. The large pharma's are the companies that have trained all of the FDA staff and also are the ones that hire the FDA staff when those guys wanna cash in their chips. Ergo, the theory goes that when a biotech company presents an NDA to the FDA, especially for a drug that will compete with large pharma's drugs, and especially for a drug where that biotech company has not collaborated with any large pharma to develop, the FDA is gonna be nasty as hell with the application.

Would be interested in folks' thoughts on this speculation.

Re: Dr. Dan, I'm gonna e-mail him and let him know how famous he is now <g>! Plus, at least then the guy can defend himself if he wants to.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext